肺结核合并肺癌影像学评估方法现状及进展

doi:10.19982/j.issn.1000-6621.20230045

摘要/Abstract

摘要：

结核病是目前全世界第二大致死性传染病。肺癌在中国的发病率和病亡率均位于恶性肿瘤中的第一位。由于肺结核和肺癌可以共存,因此对二者进行鉴别是临床工作所面临的一项挑战。随着影像学技术的快速发展,影像学检查对肺结核及肺癌的早期识别为两种疾病的诊断过程提供了指引。笔者对肺结核合并肺癌的传统影像学评估方法及研究新进展进行综述,同时分析现有影像学评估方法所面临的挑战,以及未来发展的方向。

关键词: 结核,肺, 肺肿瘤, 体层摄影术,X线, 正电子发射断层显像术, 诊断显像

Abstract:

Tuberculosis ranks second of the leading causes of communicable disease induced deaths worldwide. Lung cancer ranks first in both morbidity and mortality of malignant tumors in China. Because pulmonary tuberculosis and lung cancer can coexist, their differentiation is a clinical challenge. With the rapid development of imaging technology, the early identification of pulmonary tuberculosis and lung cancer using image evaluation provides great guide for diagnostic process of these two diseases. This paper mainly reviews the classic imaging evaluation methods and the latest research progress of novel methods for detecting pulmonary tuberculosis and lung cancer comorbidity, and analyzes the challenges of existing imaging evaluation methods and the future development direction.

Key words: Tuberculosis, pulmonary, Lung neoplasms, Tomography,X-ray, Positron-emission tomography, Diagnostic imaging

中图分类号:

R521
R81

温立旻, 侯代伦. 肺结核合并肺癌影像学评估方法现状及进展[J]. 中国防痨杂志, 2023, 45(6): 620-624. doi: 10.19982/j.issn.1000-6621.20230045

Wen Limin, Hou Dailun. Current status and progress of imaging evaluation methods for detecting pulmonary tuberculosis combined with lung cancer[J]. Chinese Journal of Antituberculosis, 2023, 45(6): 620-624. doi: 10.19982/j.issn.1000-6621.20230045

参考文献 34

[1]	World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[2]	Woodman C, Vundu G, George A, et al. Applications and strategies in nanodiagnosis and nanotherapy in lung cancer. Semin Cancer Biol, 2021, 69:349-364. doi:10.1016/j.semcancer.2020.02.009. doi: 10.1016/j.semcancer.2020.02.009 pmid: 32088362
[3]	Evman S, Baysungur V, Alpay L, et al. Management and Surgical Outcomes of Concurrent Tuberculosis and Lung Cancer. Thorac Cardiovasc Surg, 2017, 65(7):542-545. doi:10.1055/s-0036-1583167. doi: 10.1055/s-0036-1583167 pmid: 27111500
[4]	Heuvers ME, Aerts JG, Hegmans JP, et al. History of tuberculosis as an independent prognostic factor for lung cancer survival. Lung Cancer, 2012, 76(3):452-456. doi:10.1016/j.lungcan.2011.12.008. doi: 10.1016/j.lungcan.2011.12.008 pmid: 22226628
[5]	Vento S, Lanzafame M. Tuberculosis and cancer: a complex and dangerous liaison. Lancet Oncol, 2011, 12(6):520-522. doi: 10.1016/S1470-2045(11)70105-X pmid: 21624773
[6]	Bobba RK, Holly JS, Loy T, et al. Scar carcinoma of the lung: a historical perspective. Clin Lung Cancer, 2011, 12(3):148-154. doi:10.1016/j.cllc.2011.03.011. doi: 10.1016/j.cllc.2011.03.011 pmid: 21663856
[7]	Long K, Zhou H, Li Y, et al. The value of chest computed tomography in evaluating lung cancer in a lobe affected by stable pulmonary tuberculosis in middle-aged and elderly patients: A preliminary study. Front Oncol, 2022, 12:868107. doi:10.3389/fonc.2022.868107. doi: 10.3389/fonc.2022.868107
[8]	Abdeahad H, Salehi M, Yaghoubi A, et al. Previous pulmonary tuberculosis enhances the risk of lung cancer: systematic reviews and meta-analysis. Infect Dis (Lond), 2022, 54(4):255-268. doi:10.1080/23744235.2021.2006772. doi: 10.1080/23744235.2021.2006772
[9]	Bayle CH. Recherches sur la phitisue pulmonaire. Paris: Galon: 1810.
[10]	Takwoingi Y, Whitworth H, Rees-Roberts M, et al. Inter-feron gamma release assays for Diagnostic Evaluation of Active tuberculosis (IDEA): test accuracy study and economic evaluation. Health Technol Assess, 2019, 23(23):1-152. doi:10.3310/hta23230. doi: 10.3310/hta23230 pmid: 31138395
[11]	Lang S, Sun J, Wang X, et al. Asymptomatic pulmonary tuberculosis mimicking lung cancer on imaging: A retrospective study. Exp Ther Med, 2017, 14(3):2180-2188. doi:10.3892/etm.2017.4737. doi: 10.3892/etm.2017.4737 pmid: 28962139
[12]	Sun W, Zhang L, Liang J, et al. Comparison of clinical and imaging features between pulmonary tuberculosis complicated with lung cancer and simple pulmonary tuberculosis: a systema-tic review and meta-analysis. Epidemiol Infect, 2022, 150:e43. doi:10.1017/S0950268822000176. doi: 10.1017/S0950268822000176 URL
[13]	侯代伦, 柳澄. 结核病影像学. 北京: 人民卫生出版社, 2019:307-314.
[14]	Kim YI, Goo JM, Kim HY, et al. Coexisting bronchogenic carcinoma and pulmonary tuberculosis in the same lobe: radiologic findings and clinical significance. Korean J Radiol, 2001, 2(3):138-144. doi:10.3348/kjr.2001.2.3.138. doi: 10.3348/kjr.2001.2.3.138 pmid: 11752984
[15]	Oh CM, Roh YH, Lim D, et al. Pulmonary Tuberculosis is Associated with Elevated Risk of Lung cancer in Korea: The Nationwide Cohort Study. J Cancer, 2020, 11(7):1899-1906. doi:10.7150/jca.37022. doi: 10.7150/jca.37022 URL
[16]	Parker CS, Siracuse CG, Litle VR. Identifying lung cancer in patients with active pulmonary tuberculosis. J Thorac Dis, 2018, 10(Suppl 28):S3392-S3397. doi:10.21037/jtd.2018.07.11. doi: 10.21037/jtd.2018.07.11 URL
[17]	Tang W, Xing W, Li C, et al. Differences in CT imaging signs between patients with tuberculosis and those with tuberculosis and concurrent lung cancer. Am J Transl Res, 2022, 14(9):6234-6242. pmid: 36247264
[18]	Zheng L, Yin J, Wang S, et al. Associated factors of co-existent pulmonary tuberculosis and lung cancer: A case-control study. Eur J Clin Invest, 2021, 51(4):e13432. doi:10.1111/eci.13432. doi: 10.1111/eci.13432
[19]	Henschke CI, Yankelevitz DF, Miettinen OS. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med, 2006, 166(3):321-325. doi:10.1001/archinte.166.3.321. doi: 10.1001/archinte.166.3.321 pmid: 16476872
[20]	Ashizawa K, Matsuyama N, Okimoto T, et al. Coexistence of lung cancer and tuberculoma in the same lesion: demonstration by high resolution and contrast-enhanced dynamic CT. Br J Radiol, 2004, 77(923):959-962. doi:10.1259/bjr/31864795. doi: 10.1259/bjr/31864795 URL
[21]	漆婉玲, 邬莺莺, 朱雪超, 等. 高场磁共振成像在肺结核检查和诊断中的临床应用价值. 新发传染病电子杂志, 2020, 5(3):212-214. doi:10.19871/j.cnki.xfcrbzz.2020.03.016. doi: 10.19871/j.cnki.xfcrbzz.2020.03.016
[22]	Zeng J, Liu Z, Shen G, et al. MRI evaluation of pulmonary lesions and lung tissue changes induced by tuberculosis. Int J Infect Dis, 2019, 82:138-146. doi:10.1016/j.ijid.2019.03.004. doi: S1201-9712(19)30131-6 pmid: 30872041
[23]	Wei S, Shi B, Zhang J, et al. Differentiating mass-like tuberculosis from lung cancer based on radiomics and CT features. Transl Cancer Res, 2021, 10(10):4454-4463. doi:10.21037/tcr-21-1719. doi: 10.21037/tcr-21-1719 pmid: 35116302
[24]	阎辉, 杨永雁, 宋琨, 等. 磁共弥散加权成像与动态增强扫描在肺癌临床分期中联合诊断价值分析. 中国CT和MRI杂志, 2020, 18(4):39-42. doi:10.3969/j.issn.1672-5131.2020.04.013. doi: 10.3969/j.issn.1672-5131.2020.04.013
[25]	Tondo F, Saponaro A, Stecco A, et al. Role of diffusion-weighted imaging in the differential diagnosis of benign and malignant lesions of the chest-mediastinum. Radiol Med, 2011, 116(5):s720-733. doi:10.1007/s11547-011-0629-1. doi: 10.1007/s11547-011-0629-1
[26]	Du D, Gu J, Chen X, et al. Integration of PET/CT Radiomics and Semantic Features for Differentiation between Active Pulmonary Tuberculosis and Lung Cancer. Mol Imaging Biol, 2021, 23(2):287-298. doi:10.1007/s11307-020-01550-4. doi: 10.1007/s11307-020-01550-4 pmid: 33030709
[27]	Niyonkuru A, Chen X, Bakari KH, et al. Evaluation of the diagnostic efficacy of ¹⁸F-Fluorine-2-Deoxy-D-Glucose PET/CT for lung cancer and pulmonary tuberculosis in a Tuberculosis-endemic Country. Cancer Med, 2020, 9(3):931-942. doi:10.1002/cam4.2770. doi: 10.1002/cam4.2770 URL
[28]	Werutsky G, Hochhegger B, Lopes de Figueiredo Pinto JA, et al. PET-CT has low specificity for mediastinal staging of non-small-cell lung cancer in an endemic area for tuberculosis: a diagnostic test study (LACOG 0114). BMC Cancer, 2019, 19(1):5. doi:10.1186/s12885-018-5233-5. doi: 10.1186/s12885-018-5233-5 pmid: 30606144
[29]	Niyonkuru A, Bakari KH, Lan X. ¹⁸F-Fluoro-2-Deoxy-d-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease. PET Clin, 2018, 13(1):19-31. doi:10.1016/j.cpet.2017.08.003. doi: S1556-8598(17)30083-4 pmid: 29157383
[30]	Chassagnon G, Vakalopoulou M, Paragios N, et al. Artificial intelligence applications for thoracic imaging. Eur J Radiol, 2020, 123:108774. doi:10.1016/j.ejrad.2019.108774. doi: 10.1016/j.ejrad.2019.108774
[31]	Wang L. Deep Learning Techniques to Diagnose Lung Cancer. Cancers (Basel), 2022, 14(22):5569. doi:10.3390/can-cers14225569. doi: 10.3390/can-cers14225569 URL
[32]	Lakshmanaprabu SK, Mohanty SN, Shankar K, et al. Optimal deep learning model for classifification of lung cancer on CT images. Future Gener, 2019, 92:374-382. doi:10.1016/j.future.2018.10.009. doi: 10.1016/j.future.2018.10.009
[33]	Thattaamuriyil Padmakumari L, Guido G, Caruso D, et al. The Role of Chest CT Radiomics in Diagnosis of Lung Cancer or Tuberculosis: A Pilot Study. Diagnostics (Basel), 2022, 12(3):739. doi:10.3390/diagnostics12030739. doi: 10.3390/diagnostics12030739
[34]	Hu Y, Zhao X, Zhang J, et al. Value of ¹⁸F-FDG PET/CT radiomic features to distinguish solitary lung adenocarcinoma from tuberculosis. Eur J Nucl Med Mol Imaging, 2021, 48(1):231-240.doi:10.1007/s00259-020-04924-6. doi: 10.1007/s00259-020-04924-6